Chargement en cours...

Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model

Toll-like receptor (TLR) agonists have been shown to have anti-tumour activity in basic research and clinical studies. However, TLR agonist monotherapy does not sufficiently eliminate tumours. Activation of the innate immune response by TLR agonists is effective at driving adaptive immunity via inte...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Immunology
Auteurs principaux: Ito, Hiroyasu, Ando, Tatsuya, Arioka, Yuko, Saito, Kuniaki, Seishima, Mitsuru
Format: Artigo
Langue:Inglês
Publié: BlackWell Publishing Ltd 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4368168/
https://ncbi.nlm.nih.gov/pubmed/25322876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.12413
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!